Skip to main content

Table 8 Multiple logistic regression analysis

From: Renoprotective effect of febuxostat on contrast-induced acute kidney injury in chronic kidney disease patients stage 3: randomized controlled trial

 

ß estimate

95% CI (lower)

95% CI (upper)

OR / Exponential Beta

P value

Diabetes mellitus

0.006

-0.129

140

3.4

0.932

Serum Urea

-0.003

-0.009

0.003

0.107

0.258

Serum Creatinine

0.668

0.336

1.00

0.402

0.0001

Estimated GFR

-0.011

-0.025

0.004

0.203

0.153

CKD-stage

-0.091

-0.313

0.132

0.26

0.422

Mehran score

0.5

0.006

0.095

0.342

0.027

AKI-risk

0.006

0.089

-0.013

0.025

0.533

Febuxostat use

-0.123

-0.240

-0.006

0.39

0.048

  1. CI = confidence interval; OR = Odds Ratio.